Tiziana Life Sciences Ltd.: Data from Secondary Progressive

NEW YORK, June 01, 2022) ("Tiziana" or the "Company"), a biotechnology company enabling breakthrough immunotherapies via novel routes of monoclonal antibody delivery, today announced that Dr. Tanuja Chitnis

Related Keywords

China , Boston , Massachusetts , United States , Canada , Irina Koffler , Hana Malik , Tanuja Chitnis , Lifesci Advisors , Veterans Administration Ms Programs , Harvard Medical School , Consortium Of Multiple Sclerosis Centersby Tiziana On , Tiziana Life Sciences , Tiziana Life Sciences Ltd , Gems Centers , Business Development , Multiple Sclerosis , Multiple Sclerosis Centersby Tiziana , Blood Inflammatory Biomarkers , Non Active Secondary Progressive , Harvard Medical , Life Sciences , Investor Relations , Sci Advisors , Tiziana , Life , Ciences , Data , Rom , Secondary , Progressive , Multiple , Clerosis , Patient , Reated , Intranasal , Treatment , Foralumab , Resented , Consortium , Centers , Msc , 022 , Nnual , Meeting ,